Showing Results for: “Glycemic Index and Diabetes”

New guidelines include recommendations for the detection and management of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH) in people with diabetes Today, the American Diabetes Association ® (ADA) published updates in the Standards of Care in Diabetes—2023 (Standards of Care) based on the latest scientific research and clinical trials. Liver disease affects up to 70% of people with type 2 diabetes. Nonalcoholic fatty liver disease (NAFLD), which includes nonalcoholic steatohepatitis (NASH), is the most common form of liver disease in people with diabetes. NAFLD can

Addressing Health Disparities and Precision Medicine to Improve Outcomes, Among Top Priorities Today, the American Diabetes Association ® (ADA) released its 2022 Annual Research Report, which provides background and updates on 200 grants awarded to fund critical research in new treatments and cures for diabetes, precision medicine, and new methods for addressing the health inequities that lead to higher prevalence of diabetes and prediabetes. “Our research investments are targeted to solve problems critical to people with diabetes. These include reducing unjust health disparities, achieving

Today, Delaware Governor John Carney signed Senate Bill 316 to cap monthly costs of diabetes supplies and equipment, ensuring people living with diabetes have access to these necessities, an important step to reducing the overall cost of diabetes. Diabetes equipment and supplies are integral to proper diabetes care and will promote better management while protecting the health and well-being of those living with diabetes. They are necessary for administering insulin and for monitoring blood glucose levels every day. Cost sharing for diabetes equipment and supplies can be as burdensome as the

To improve gaps in type 2 diabetes care within health care systems and to reduce cardiovascular deaths, heart attacks and strokes for people living with type 2 diabetes, the American Diabetes Association (ADA) and the American Heart Association (AHA) announce the inclusion of their respective, industry-recognized quality improvement programs, Diabetes INSIDE® and Get With The Guidelines®, as part of the Know Diabetes by HeartTM initiative. Additionally, AstraZeneca joins founding sponsors Boehringer Ingelheim and Eli Lilly and Company Diabetes Alliance and Novo Nordisk, and national sponsor

The American Diabetes Association (ADA) applauds the re-introduction of the Expanding Access to Diabetes Self-Management Training (DSMT) Act in the U.S. Senate. The ADA thanks Senate Diabetes Caucus co-chairs Senator Jeanne Shaheen (D-NH) and Senator Susan Collins (R-ME) for re-introducing this important legislation which will expand access to DSMT services for people with diabetes who are on Medicare. DSMT is an evidence-based program that teaches people living with diabetes how to cope with and manage their diabetes and reduce their risk for complications by monitoring their blood sugar

CEO Tracey D. Brown Urges All States to Follow CDC’s Guidance The American Diabetes Association® (ADA) applauds the Centers for Disease Control and Prevention (CDC) for recognizing and prioritizing all people with diabetes for a COVID-19 vaccination. In updated guidance released yesterday on the CDC website, the CDC acknowledges the message advanced by ADA and other diabetes community leaders, stating, “having either type 1 or type 2 diabetes can make you more likely to get severely ill from COVID-19.” This updated guidance will help to address the fact that in many states, millions of people

Denmark study of self-reported data from more than 9,000 people finds overall need for better access to psychological and other non-medical diabetes care for people living with diabetes and their caregivers Results presented today at the American Diabetes Association’s® (ADA’s) 80th Virtual Scientific Sessions show 18% of people living with diabetes in Denmark needed a referral for a psychologist but had not been offered one, and 36% said they did not receive the support they needed to cope with their emotions related to diabetes. The research was compiled through the study, “Psychological

The U.S. Postal Service (USPS) plays a vital role in the lives of all Americans and, in the context of the current pandemic, this role is now more pronounced than ever. This is particularly true for the 34 million Americans with diabetes, because so many of them rely on the U.S. mail for shipments of medication and medical supplies. Put simply, delays in mail shipments of medications put these lives at risk. "Even greater numbers of people with diabetes – who are at uniquely high risk for the worst COVID-19 outcomes – are having their medications mailed to them to ensure they limit unnecessary

SGLT2i Shown as Potential Solution to Help Manage Renal Complications and Improve Glycemic Control for Young Individuals Living with Type 1 Diabetes Today, findings from the ATTEMPT study, showed that a low-dose of SGLT2 inhibitor could safely be given to youth and adolescents with type 1 diabetes to improve kidney function and glycemic management. ATTEMPT is the first of its kind, landmark trial designed to evaluate the effectiveness of SGLT2 inhibitors to optimize diabetes control and prevent early subclinical kidney complications in an at-risk pediatric population with type 1 diabetes. The